Studies in a mouse model of cortical infarction have shown that GITR, triggering on CD4+ T cells, increases post-stroke inflammation and decreases the number of neural stem/progenitor cells induced by ischemia (iNSPCs). This evidence concerns the gene CD4 and Stroke.